Lactobacillus salivarius UCC118 and Reduced Colitis Severity

• Lactobacillus salivarius UCC118™ Dampens Inflammation and Promotes Microbiota Recovery to Provide Therapeutic Benefit in a DSS-Induced Colitis Model

  • 2022-07-09
  • Clinical Trial
  • Microorganisms 10(7)
  • • N. Iyer
    • Michelle A Williams
    • A. O’Callaghan
    • E. Dempsey
    • R. Cabrera-Rubio
    • Mathilde Raverdeau
    • F. Crispie
    • P. Cotter
    • S. Corr

  • PubMed: 35889102
  • DOI: 10.3390/microorganisms10071383

  11 Insights on

  • Reduced Colitis Severity

  • Low evidence
  • Rigorous Journal
  • Animal Study
  • Clinical

  In the pre-treatment model of colitis, UCC118TM reduced the severity of the disease in the early stages.

  Effect

  Beneficial

  Effect size

  Large